Home
Conditions
Small Cell Lung Carcinoma

Clinical trial condition

Small Cell Lung Carcinoma

Explore clinical trials studying Small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.

820 public trials 197 recruiting studies

Refine in advanced search Browse all conditions

Small Cell Lung Carcinoma trial results

Not Yet Recruiting

DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer

NCT07545954

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +9 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Not Yet Recruiting

Epigenomic Profiling of Circulating Cell-Free DNA (cfDNA) to Characterize the Dynamic Evolution of Molecular Subtypes in Extensive-Stage Small Cell Lung Cancer During First-Line Chemoimmunotherapy

NCT07670442

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)

NCT07488923

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +20 more
Locations: Hackensack University Medical Center Hackensack, New Jersey, United States

NYU Langone Health New York, United States

Sarah Cannon Research Institute (SCRI) Nashville, Tennessee, United States

UT Southwestern Medical Center Dallas, Texas, United States

View Trial Details

Not Yet Recruiting

Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC)

NCT07007325

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Institut de cancérologie de l'ouest Angers, France

CHU d'Angers Angers, France

Institut de cancérologie de l'ouest Saint-Herblain, France

View Trial Details

Not Yet Recruiting

A Study of BL-M14D1 in Combination With Atezolizumab in Patients With Extensive-stage Small Cell Lung Cancer

NCT07654400

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations: Shanghai East Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer

NCT07640932

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Small Cell Lung, +8 more
Locations: Yonsei University Health System, Severance Hospital Seoul, South Korea

View Trial Details

Not Yet Recruiting

Tarlatamab and Durvalumab vs. Durvalumab Alone for Limited-Stage-Small Cell Lung Cancer

NCT07637513

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Limited Stage Small-Cell Lung Cancer, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung Cancer

NCT07636226

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Phase II Study of GV20-0251 in Combination With Anti-PD-1 Monoclonal Antibodies in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors.

NCT07623642

Conditions: Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +55 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

View Trial Details

Not Yet Recruiting

A First-in-Human Study of HH160 in Patients With Advanced Solid Tumors

NCT07623369

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +69 more
Locations: Not specified

View Trial Details

Small Cell Lung Carcinoma

Small Cell Lung Carcinoma trial results

Related conditions